Folic Acid Clinical Trial for the Prevention of Cervical Cancer

Completed · Phase 2 · Has a placebo group

Conditions studied: Cervical Cancer, Precancerous Condition

In brief

RATIONALE: Supplements, such as folic acid, may stop or delay the development of cervical cancer in women infected with human papillomavirus. PURPOSE: This phase II trial is studying how well folic acid supplements work in preventing cancer in women infected with human papillomavirus.

Key facts

Study ID

NCT00703196

Run by

University of Alabama at Birmingham

People needed

368

Starts

2007-03-01

Last updated by the study team

2015-10-08

Who can join

Age: 19 and older, up to 120. Sex: female. Healthy volunteers: not accepted.

Where it is running

• UAB Comprehensive Cancer Center — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.